Eric M. Reiman, M.D., serves as deputy editor of this section, which encourages scientific studies of Alzheimer’s disease, promotes the optimal care of patients, and helps to keep the psychiatric community informed of the latest scientific and clinical developments. See our information on submitting a manuscript to this section.
Entering the Era of High-Density Genome-Wide Association Studies
[PDF]
A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's Disease
Clinical Trials and Tribulations
[PDF]
Study Design Factors and Patient Demographics and Their Effect on the Decline of Placebo-Treated Subjects in Randomized Clinical Trials in Alzheimer's Disease
Antiaggressive Effect of Cyproterone Versus Haloperidol in Alzheimer's Disease: A Randomized Double-Blind Pilot Study
Helping Families With End-of-Life Care in Alzheimer's Disease
The Non-Alzheimer Dementias
[PDF]
A Review of the Non-Alzheimer Dementias
A 100-Year Update on Alzheimer's Disease and Related Disorders
[PDF]
Alzheimer's Disease A Century Later
The Genetic, Transcriptomic, and Proteomic Study of Alzheimer's Disease
[PDF]
Genetics, Transcriptomics, and Proteomics of Alzheimer's Disease
Genetics, Cholesterol, and the Risk of Alzheimer's Disease
[PDF]
A Cluster of Cholesterol-Related Genes Confers Susceptibility for Alzheimer's Disease